Evidence map›Paper›PMID 32894241›Full record

ArticleJournal of Alzheimer's disease : JAD2020

Utility of MemTrax and Machine Learning Modeling in Classification of Mild Cognitive Impairment.

Michael F Bergeron, Sara Landset, Xianbo Zhou, Tao Ding, Taghi M Khoshgoftaar, Feng Zhao, Bo Du, Xinjie Chen, Xuan Wang, Lianmei Zhong and 2 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Toward digitally screening and profiling AD: A GAMLSS approach of MemTrax in China.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
  8. Article
  9. Article
  10. Mild Cognitive Impairment: Data-Driven Prediction, Risk Factors, and Workup.AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2023
    Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Michael F BergeronSIVOTEC Analytics, Boca Raton, FL, USA.
Sara LandsetDepartment of Computer and Electrical Engineering and Computer Science, Florida Atlantic University, Boca Raton, FL, USA.
Xianbo ZhouSJN Biomed LTD, Kunming, Yunnan, China.
Tao DingDepartment of Rehabilitation Medicine, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Taghi M KhoshgoftaarDepartment of Computer and Electrical Engineering and Computer Science, Florida Atlantic University, Boca Raton, FL, USA.
Feng ZhaoDepartment of Neurology, Dehong People's Hospital, Dehong, Yunnan, China.
Bo DuDepartment of Rehabilitation Medicine, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Xinjie ChenDepartment of Neurology, the First Affiliated Hospital of Kunming Medical University, Wuhua District, Kunming, Yunnan Province, China.
Xuan WangDepartment of Rehabilitation Medicine, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Lianmei ZhongDepartment of Neurology, the First Affiliated Hospital of Kunming Medical University, Wuhua District, Kunming, Yunnan Province, China.
Xiaolei LiuDepartment of Neurology, the First Affiliated Hospital of Kunming Medical University, Wuhua District, Kunming, Yunnan Province, China.
J Wesson AshfordWar-Related Illness and Injury Study Center, VA Palo Alto Health Care System, Palo Alto, CA, USA.
Kunming Medical University · CNFlorida Atlantic University · USInstitute of Clinical Research · USVA Palo Alto Health Care System · USZhongshan People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe widespread incidence and prevalence of Alzheimer's disease and mild cognitive impairment (MCI) has prompted an urgent call for research to validate early detection cognitive screening and assessment.

objectiveOur primary research aim was to determine if selected MemTrax performance metrics and relevant demographics and health profile characteristics can be effectively utilized in predictive models developed with machine learning to classify cognitive health (normal versus MCI), as would be indicated by the Montreal Cognitive Assessment (MoCA).

methodsWe conducted a cross-sectional study on 259 neurology, memory clinic, and internal medicine adult patients recruited from two hospitals in China. Each patient was given the Chinese-language MoCA and self-administered the continuous recognition MemTrax online episodic memory test on the same day. Predictive classification models were built using machine learning with 10-fold cross validation, and model performance was measured using Area Under the Receiver Operating Characteristic Curve (AUC). Models were built using two MemTrax performance metrics (percent correct, response time), along with the eight common demographic and personal history features.

resultsComparing the learners across selected combinations of MoCA scores and thresholds, Naïve Bayes was generally the top-performing learner with an overall classification performance of 0.9093. Further, among the top three learners, MemTrax-based classification performance overall was superior using just the top-ranked four features (0.9119) compared to using all 10 common features (0.8999).

conclusionMemTrax performance can be effectively utilized in a machine learning classification predictive model screening application for detecting early stage cognitive impairment.

Indexed as

Mental Status and Dementia TestsModels, PsychologicalAgedCognitive DysfunctionCross-Sectional StudiesFemaleHumansMachine LearningMaleMiddle AgedNeuropsychological TestsAgingAlzheimer’s diseasedementiamass screening

Identifiers

PMID32894241
PMCPMC7683062
OpenAlexW3083333873

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.